Drug
venlafaxine (Effexor)
venlafaxine (Effexor) is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
3
75%
Ph phase_2
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
3(75.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (25.0%)
Phase 43 (75.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_4
Physiologic Monitoring of Antidepressant Response
NCT00792168
completedphase_4
Physiologic Monitoring of Antidepressant Treatment Response
NCT00759317
completedphase_4
Electroencephalography (EEG) Biomarkers of Response in Depression
NCT00759122
completedphase_2
Acute Effectiveness of Additional Drugs to the Standard Treatment of Depression
NCT00001483
Clinical Trials (4)
Showing 4 of 4 trials
NCT00792168Phase 4
Physiologic Monitoring of Antidepressant Response
NCT00759317Phase 4
Physiologic Monitoring of Antidepressant Treatment Response
NCT00759122Phase 4
Electroencephalography (EEG) Biomarkers of Response in Depression
NCT00001483Phase 2
Acute Effectiveness of Additional Drugs to the Standard Treatment of Depression
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4